Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy
<p>Abstract</p> <p>Small-cell lung cancer (SCLC) is the most aggressive lung cancer subtype and lacks effective early detection methods and therapies. A number of rare paraneoplastic neurologic autoimmune diseases are strongly associated with SCLC. Most patients with such paraneopl...
Main Authors: | Laird-Offringa Ite A, Kazarian Meleeneh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/10/1/33 |
Similar Items
-
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
by: Laird-Offringa Ite A, et al.
Published: (2008-10-01) -
Data on isoaspartylation of neuronal ELAVL proteins
by: Mario A. Pulido, et al.
Published: (2016-12-01) -
Epigenetic Therapy in Lung Cancer
by: Stephen V Liu, et al.
Published: (2013-05-01) -
Early detection of lung cancer by using an autoantibody panel in Chinese population
by: Shengxiang Ren, et al.
Published: (2018-02-01) -
Autoantibodies as the Early Diagnostic Biomarkers for Lung Cancer
by: Yibing YAO, et al.
Published: (2010-09-01)